01Apr 2023
Nirogacestat effective in desmoid tumours

Nirogacestat effective in desmoid tumours

Desmoid tumours are rare, locally aggressive, but typically nonmetastatic soft-tissue tumors for which no systemic therapy is currently approved. Although rarely lethal, these fast-growing tumours can lead to substantial comorbidities. Now, data from the phase III DeFi trial demonstrate the efficacy of the γ-secretase inhibitor nirogacestat in patients with progressing desmoid tumours.

  • #oncology

Like

Save

Share